Table 1. Patient demographics and clinical characteristics at diagnosis.
Clinical characteristics | No. of patients (%) |
---|---|
Gender | |
Male | 162 (73) |
Female | 61 (27) |
Age, years | |
Median | 71 |
Quartiles | 66–77 |
ECOG Performance status | |
0 | 43 (19) |
1 | 74 (33) |
⩾2 | 106 (48) |
Hydronephrosis | 81 (37) |
Primary site | |
Bladder | 190 (59) |
Non-bladder | 91 (41) |
Prior definitive therapy | 168 (75) |
Lymph node metastasis | 129 (42) |
Any visceral metastasis | 117 (47) |
Liver | 26 (12) |
Bone | 50 (23) |
Lung | 55 (25) |
WBC | |
Median | 6900 |
Quartiles | 5400–9000 |
Haemoglobin, g dl −1 | |
⩾10 | 162 (73) |
<10 | 61 (27) |
Creatinine, mg dl −1 | |
Median | 1.09 |
Quartiles | 0.8–1.37 |
Albumin, g dl −1 | |
Median | 3.60 |
Quartiles | 3.10–4.00 |
ALP, U l −1 | |
Median | 257.0 |
Quartiles | 208.0–348.2 |
LDH, U l −1 | |
Median | 221.0 |
Quartiles | 180.0.0–311.0 |
Corrected calcium, mg dl −1 | |
Median | 9.188 |
Quartiles | 8.922–9.471 |
CRP, mg l −1 | |
Median | 15.0 |
Quartiles | 2.0–54.0 |
Abbreviations: ALP=alkaline phosphatase; LDH=lactate dehydrogenase; CRP=C-reactive protein; ECOG=Eastern Cooperative Oncology Group; WBC=white blood cell.